Literature DB >> 16401854

Cardiac encephalopathy and congestive heart failure: a hypothesis about the relationship.

Louis R Caplan1.   

Abstract

Many patients with congestive heart failure develop neurologic dysfunction. This may take the form of a cardiac encephalopathy that shares clinical features with other metabolic encephalopathies. The causes are multiple. There is a particular, previously unreported, syndrome that occasionally develops in some patients with congestive heart failure that resembles the findings in patients with normal pressure hydrocephalus. This syndrome is characterized by apathy and abulia with preserved alertness; it is caused by fluid retention within the cranial cavity. The syndrome may also develop in patients with other conditions that cause anasarca, e.g., severe liver or kidney disease or hypoalbuminemia. Because patients with these conditions are often quite ill, it has been difficult to verify the pathophysiologic aspects of the syndrome so that its mechanism must remain a hypothesis that awaits more definitive study in a series of patients. I have not seen this syndrome discussed in any cardiology or neurology texts or reports, and it seems to be completely unknown to cardiologists and neurologists. I have recognized about one patient per year with this syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 16401854     DOI: 10.1212/01.wnl.0000191327.62136.b1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Respiration: A New Mechanism for CSF Circulation?

Authors:  Alberto Delaidelli; Alessandro Moiraghi
Journal:  J Neurosci       Date:  2017-07-26       Impact factor: 6.167

2.  Early onset probable linezolid-induced encephalopathy.

Authors:  Jeffery Fletcher; Laura E Aykroyd; Eric C Feucht; James M Curtis
Journal:  J Neurol       Date:  2009-11-05       Impact factor: 4.849

Review 3.  New concepts in the pathogenesis of hydrocephalus.

Authors:  Satish Krishnamurthy; Jie Li
Journal:  Transl Pediatr       Date:  2014-07

4.  A unifying hypothesis for hydrocephalus, Chiari malformation, syringomyelia, anencephaly and spina bifida.

Authors:  Helen Williams
Journal:  Cerebrospinal Fluid Res       Date:  2008-04-11

5.  B-type (brain) natriuretic peptide and pruritus in hemodialysis patients.

Authors:  Yoshio Shimizu; Ayano Sonoda; Chieko Nogi; Yoko Ogushi; Reo Kanda; Saori Yamaguchi; Nao Nohara; Tatsuya Aoki; Kaori Yamada; Junichiro Nakata; Hiroaki Io; Atsushi Kurusu; Chieko Hamada; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-08-25

6.  The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure.

Authors:  Koichi Narita; Eisuke Amiya; Nobutaka Kakuda; Hidehiro Kaneko; Masaru Hatano; Issei Komuro
Journal:  Diagnostics (Basel)       Date:  2020-01-27

7.  Lower Blood Pressure, Small-Vessel Disease, and Apathy in Older Persons With Mild Cognitive Deficits.

Authors:  Anne Suzanne Bertens; Jessica C Foster-Dingley; Jeroen van der Grond; Justine E F Moonen; Roos C van der Mast; Nathaly Rius Ottenheim
Journal:  J Am Geriatr Soc       Date:  2020-04-30       Impact factor: 5.562

8.  Stroke Classification: Critical Role of Unusually Large von Willebrand Factor Multimers and Tissue Factor on Clinical Phenotypes Based on Novel "Two-Path Unifying Theory" of Hemostasis.

Authors:  Jae C Chang
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

9.  Factors contributing to global cognitive impairment in heart failure: results from a population-based cohort.

Authors:  Patrick M Pullicino; Virginia G Wadley; Leslie A McClure; Monika M Safford; Ronald M Lazar; Marc Klapholz; Ali Ahmed; Virginia J Howard; George Howard
Journal:  J Card Fail       Date:  2008-05       Impact factor: 5.712

Review 10.  Heart failure and cognitive impairment: challenges and opportunities.

Authors:  George A Heckman; Christopher J Patterson; Catherine Demers; Joye St Onge; Irene D Turpie; Robert S McKelvie
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.